|
 |
MesalamineThis page contains recent news articles, when available, and an overview of Mesalamine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....and sodium phosphate dibasic anhydrous, USP) Tablets, APRISOâ„¢ (mesalamine) extended-release capsules 0.375 g., METOZOLV TM ODT (metoclopramide HCl), ... PharmaLive.com (press release) æ—¥ ì œì•½ì—…ê³„ 올해ì—?ë?„ M&A 잇따ë?¼ - Dec 30, 2009 ...티롯ì?€ ì—¼ì¦?성 장질환 ì¹˜ë£Œì œ '아사콜'(Asacol, mesalamine)ì?´ íŒ?매구성비ì?˜ 81%를 ì°¨ì§€í• ì •ë?„ë¡œ 하부소화기분야ì—? ê°•í•œ ì „ë¬¸ì œì•½íšŒì‚¬ë¡œ, ìœ ëŸ½ê³¼ 중ë?™ 등 세계 50ê°œêµ ... 디지틀보사 Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 ... - Oct 26, 2009 ..."The results of the Lialda and 5-ASA persistency analyses will provide insights as to how UC patients manage their mesalamine prescription refills. ... Reuters Patients Previously on Steroids Maintain Remission From Ulcerative Colitis ... - Oct 27, 2009 ..."This data further demonstrates that mesalamine granules 1.5 g is a safe and effective option to maintain remission, even for ulcerative colitis patients ... DG News Real-World Patient Experiences on Medications for Chronic Conditions ... - Oct 26, 2009 ..."Disease education and follow-up questions were a part of the baseline survey, including strategies for managing UC and how MMX mesalamine works, ... Reuters Study demonstrates once-daily dose of Asacol(R) (mesalamine) is comparable to ... - Oct 28, 2009 ...called the QD dosing investigation for efficacy IN UC maintenance (QDIEM), found that once-daily dosing of Asacol(R) (mesalamine) delayed-release 400 mg ... CNW Telbec (Communiqué de presse) Patients With Ulcerative Colitis Who Have Worst Baseline Disease Are Most ... - Oct 29, 2009 Dr. Lichtenstein noted that, in the 2 studies, treatment with mesalamine granules also predicted that patients were more likely to remain in remission, ... DG News Salix Pharmaceuticals Previews American College of Gastroenterology 2009 ... - Oct 26, 2009 Long-Term Maintenance with Mesalamine Granules (1.5 g) in Patients Previously Treated with Corticosteroids is Associated with a Low Incidence of Ulcerative ... Reuters REG-Shire plc: 3rd Quarter Results - Oct 30, 2009 US oral mesalamine market share Shire's average market share of the US oral mesalamine market was 33% for the three months to September 30, 2009. ... Reuters Salix Pharmaceuticals to Present at Credit Suisse Conference - Nov 4, 2009 USP, and sodium phosphate dibasic anhydrous, USP) Tablets, APRISO (mesalamine) extended-release capsules 0.375 g., METOZOLV ODT (metoclopramide HCl), ... Reuters Salix Pharmaceuticals Reports 3Q2009 Results - Nov 9, 2009 USP, and sodium phosphate dibasic anhydrous, USP) Tablets, APRISOâ„¢ (mesalamine) extended-release capsules 0.375 g, METOZOLVâ„¢ ODT (metoclopramide HCl), ... WELT ONLINE Warner Chilcott acquires global pharmaceuticals business of Procter & Gamble - Oct 30, 2009 Under the terms of the agreement, Warner Chilcott will acquire P&G's portfolio of branded pharmaceutical products, including Asacol HD (mesalamine) ... Trading Markets (press release) Salix Pharmaceuticals, Ltd. - Pharmaceuticals & Healthcare - Deals and ... - Nov 13, 2009 PEPCID (famotidine) for Oral Suspension; Oral Suspension DIURIL (Chlorothiazide); APRISO (mesalamine) extended-release capsules 0.375 grams, ... PR-inside.com (press release) Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to ... - Nov 3, 2009 USP, and sodium phosphate dibasic anhydrous, USP) Tablets, APRISO (mesalamine) extended-release capsules 0.375 g., METOZOLV ODT (metoclopramide HCl), ... Reuters æ—¥ '서바ë¦ìŠ¤' 'ìž?누비아' 등 ì‹ ì•½ 대거 승ì?¸ - Oct 20, 2009 ...ì œë¦¬ì•„ì‹ ì•½ì?˜ 궤양성대장염 ì¹˜ë£Œì œ '아사콜'(Asacol, mesalamine)ê³¼ 다ì?´ë‹›í?°ìŠ¤ë¯¸í† ëª¨ì œì•½ì?˜ 간세í?¬ì•” ì¹˜ë£Œì œ '미리플ë?¼'(Miripla, miriplatin)ë?„ 승ì?¸ë??다. ... 디지틀보사 Ulcerative Colitis Medications - Ulcerative Colitis Health Information... - Feb 20, 2008 This drug combines the 5-ASA drug mesalamine with sulfapyridine, ... Mesalamine can cause kidney problems and should be used with caution by patients with ... New York Times Salix's Colazal Conundrum - Dec 31, 2007 On Monday Salix announced it submitted an application to the Food and Drug Administration for marketing approval for granulated mesalamine, an anti-ulcer ... Forbes Mesalamine Foam Enema Versus Mesalamine Liquid Enema in Active … - Jan 31, 2008 To determine in a noninferiority study whether mesalamine foam is as effective as mesalamine liquid enema for inducing clinical remission in patients with ... Nature.com Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the ... - Feb 23, 2005 Correspondence: Stephen B. Hanauer, MD, Division of Gastroenterology, University of Chicago Medical Center, 5841 South Maryland, Chicago, IL 60637 ... Nature.com MMX Mesalamine Induces Remission Of Ulcerative Colitis - May 25, 2006 A novel formulation of Multi-Matrix SystemTM (MMX) mesalamine (MesavanceTM) induces remission in patients with active mild-to- moderate ulcerative colitis ... Medical News Today - Medical News Today (press release) FDA approves LIALDAâ„¢ (mesalamine) - Jan 16, 2007 Basingstoke, UK and Philadelphia, US – January 16, 2007 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the US Food and Drug ... eurekalert.org Shire seeks approval for colitis drug Mesavance from US regulators - Dec 22, 2005 If approved, the product will be the first available once-daily mesalamine treatment for active, mild-to-moderate ulcerative colitis, Shire said. ... Forbes … Today Demonstrate That Mesalamine Granules Maintain Remission in … - Jul 10, 2008 Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that 1.5 g mesalamine granules once-daily maintained remission versus placebo in ulcerative ... FINANZEN.NET NEWS - FINANZEN.NET NEWS Studies Show MMX Mesalamine Induced Remission of Ulcerative Colitis - May 30, 2006 LOS ANGELES, CA -- May 30, 2006 -- Combined results of two pivotal phase III clinical studies (301 and 302) of a novel formulation of Multi-Matrix Systemâ„¢ ... DG News Patients With UC Remain in Remission After 12 Months of Mesalamine … - Nov 2, 2007 In a related study, MMX mesalamine was efficacious for remission ... The research looked at the efficacy of 2.4 g MMX mesalamine given once daily or 1.2 g ... Medscape … Today Demonstrate That Mesalamine Granules Maintain Remission in … - Oct 7, 2008 ORLANDO, FL--(Marketwire - October 7, 2008) - Salix Pharmaceuticals, Ltd. ( NASDAQ : SLXP) today announced that 1.5 g mesalamine granules once-daily ... marketwire.com Cosmo sees higher income from improved licence - Jun 6, 2007 Mezavant, which is due to be launched in Europe shortly, is the first and only FDA-approved once-daily formulation of mesalamine -- a drug often used as a ... Reuters … Colitis Responds to Once-Daily Mesalamine Formulation: Presented... - Nov 3, 2005 ...[Presentation title: Comparison of the Efficacy and Safety of SPD476, a Novel, Once-Daily, High-Dose Formulation of Mesalamine, and Asacol with Placebo for ... DG News Learn about Mesalamine from Consumer Reports Health. - Jan 10, 2006 Mesalamine is used to treat ulcerative colitis (a condition in which part or all of the lining of the colon [large intestine] is swollen or worn away). ... consumerreports.org MMX Mesalamine Induces Remission in Patients With Mild or Moderate … - Oct 23, 2007 By Danny Kucharsky. PHILADELPHIA, PA -- October 23, 2007 -- More than 60% of patients with mild or moderate ulcerative colitis remain in remission after 12 ... DG News Mesalamine (Oral).(Drug overview) - May 1, 2006 Mesalamine (me-SAL-a-meen) is used to treat inflammatory bowel disease, such as ulcerative colitis. It works inside the bowel by helping to reduce the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Once-daily formulation of mesalamine induces, maintains remission in ... - Jan 1, 2007 A once-daily formulation of mesalamine that relies on multimatrix (MMX) technology is effective at inducing and maintaining remission in patients with ... Free with registration - Formulary - AccessMyLibrary.com Mesalamine (Oral). - Aug 1, 2006 Mesalamine (me-SAL-a-meen) is used to treat inflammatory bowel disease, such as ulcerative colitis. It works inside the bowel by helping to reduce the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Aminosalicylates for inflammatory bowel disease - Oct 9, 2008 Mesalamine (Canasa, Rowasa) is placed in the rectum as a retention enema or ... About 80% of people who can't take sulfasalazine can use mesalamine without ... WebMD Mesalamine Reduces Risk of Colorectal Cancer Among IBD Patients - Oct 16, 2007 NEW YORK OCT 16, 2007 (Reuters Health) - In a case-control study, the anti-inflammatory drug mesalamine protected against the development of colorectal ... Cancerpage.com Once-daily mesalamine stalls ulcerative colitis.(Gastroenterology) - Dec 15, 2005 HONOLULU -- A novel, once-daily high-strength formulation of 5-aminosalicylic acid proved effective for the induction of remission and other end points in ... Free with registration - Internal Medicine News - AccessMyLibrary.com … Shows Treatment Response to Mesalamine Associated With Rapid … - Oct 24, 2006 LAS VEGAS, Oct. 24, 2006 /PRNewswire/ -- Combined data analysis from two trials demonstrated that treatment success is associated with mucosal healing in ... Free with registration - PR Newswire - AccessMyLibrary.com Shire and TAP Agree to Co-promote LIALDA - Mar 26, 2008 Shire's GI team has made Lialda the fastest growing brand of mesalamine and ... Once-daily LIALDA with MMX technology contains the highest mesalamine dose ... prnewswire.co.uk … (mesalamine), The First Oral Once-Daily Mesalamine For Patients... - Jan 21, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the US Food and Drug Administration (FDA) has approved LIALDATM (mesalamine) with MMX(R) ... Medical News Today - Medical News Today (press release) Mesalamine Improves Moderately Active Ulcerative Colitis - Jun 4, 2008 SAN DIEGO -- In a study presented at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, 70 percent of patients with moderately active ... EndoNurse Higher Dose of Mesalamine Is More Effective in Moderately Active … - May 17, 2005 CHICAGO, May 17 /PRNewswire/ -- Two recent studies have found that for patients with moderately active ulcerative colitis, beginning treatment with twice ... $4.95 - PR Newswire - ECNext … Shows Treatment Response To Mesalamine Associated With Rapid … - Oct 25, 2006 Combined data analysis from two trials demonstrated that treatment success is associated with mucosal healing in patients with moderately active ulcerative ... Medical News Today - Medical News Today (press release) … Analysis LIALDA(R) (mesalamine) And Asacol(R) (mesalamine) For The... - Oct 7, 2008 MMX Mesalamine Therapy for the Induction of Remission Beyond Eight Weeks: How ... Mesalamine has been associated with an acute intolerance syndrome (3% of ... Medical News Today - Medical News Today (press release) … Colitis Responds to Once-Daily Mesalamine Formulation: Presented... - Nov 8, 2005 ...[Presentation title: Comparison of the Efficacy and Safety of SPD476, a Novel, Once-Daily, High-Dose Formulation of Mesalamine, and Asacol with Placebo for ... DG News … Significant Top-Line Results of a Unique Granulated Mesalamine … - Sep 5, 2007 This granulated mesalamine formulation is unique in that it combines an enteric ... Additionally, granulated mesalamine, if and when approved by the FDA, ... $4.95 - Business Wire - ECNext Taking Mesalamine from Consumer Reports Health. - Jan 10, 2006 Mesalamine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:. Some side effects can be serious. ... consumerreports.org … , Protein Design expand collaboration; Mesalamine studies hit... - Oct 31, 2005 Two Phase III clinical studies of an advanced formulation of high-strength mesalamine, SPD476, being developed by Shire met their primary endpoints. Release ... FierceBiotech … (TM) Technology - the First Oral Once-Daily Mesalamine for Active,... - Mar 19, 2007 BASINGSTOKE, England and PHILADELPHIA, March 19 /PRNewswire-FirstCall/ -- Shire plc today announced the availability of LIALDA(TM) (mesalamine) with MMX(TM) ... RedOrbit How to take Mesalamine from Consumer Reports Health. - Jan 10, 2006 ...tell your doctor and pharmacist if you are allergic to mesalamine, balsalazide (Colazal); olsalazine (Dipentum); salicylate pain relievers such as aspirin, ... consumerreports.org Mesalamine 1-g Once-Daily Suppository as Effective as 0.5 g Three … - May 22, 2008 By Ed Susman. SAN DIEGO -- May 22, 2008 -- Treatment of mild to moderate active ulcerative proctitis can be simplified without increasing adverse effects or ... DG News … (TM) Technology The First Oral Once-Daily Mesalamine For Active,... - Mar 20, 2007 Shire plc (London: SHP, Nasdaq: SHPGY, Toronto: SHQ) today announced the availability of LIALDATM (mesalamine) with MMXTM Technology, indicated for the ... Medical News Today - Medical News Today (press release) Press Release: Higher Dose of Mesalamine is More Effective in … - May 17, 2005 Higher Dose of Mesalamine is More Effective in Moderately Active Ulcerative Colitis. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research … Application of MESAVANCE(TM) (mesalamine) With MMX Technology. - Sep 8, 2006 SPD465 (ADHD), MESAVANCE(TM) (mesalamine with MMX technology) (SPD476) (ulcerative colitis), ELAPRASE(TM) (I2S) (Hunter syndrome) and NRP104 (ADHD), ... $4.95 - PR Newswire - ECNext … LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine - Mar 26, 2008 Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative ... Pay-Per-View - PR Newswire - HighBeam Research … Announces Filing of MESAVANCE(TM) (mesalamine) for Treatment of … - Dec 22, 2005 Shire Announces Filing of MESAVANCE(TM) (mesalamine) for Treatment of Ulcerative Colitis. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research First Oral Once-Daily Mesalamine For Ulcerative Colitis: LIALDA … - Mar 23, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) has announced the availability of LIALDA® (mesalamine) with MMXTM Technology, indicated for the induction of ... Medical News Today - Medical News Today (press release) … During Digestive Disease Week (DDW) Show MMX Mesalamine ( … - May 24, 2006 The data demonstrated that MMX mesalamine induced remission in patients with ... Mesalamine is used as a first-line treatment for mild-to-moderate UC. ... RedOrbit Axcan Launches CANASA 1000 Mg in the US - Feb 28, 2005 In the United States, the rectal mesalamine market is valued at approximately US $82 million annually. According to IMS Health data published in December ... RedOrbit … Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at … - Oct 15, 2007 PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire ... Free with registration - PR Newswire - AccessMyLibrary.com IBD & Pap Smears, Mesalamine Reduces Colon Cancer - May 30, 2008 Just a brief update on my blog from last week . . . I met my deadline late last Friday and by Sunday my gut was much happier and pretty much back to normal. ... HealthCentral.com … Shows Treatment Response to Mesalamine Associated With Rapid … - Oct 24, 2006 Analysis Shows Treatment Response to Mesalamine Associated With Rapid Mucosal Healing in Patients With Moderately Active Ulcerative Colitis. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Mesalamine Linked to Cancer Protection for High Risk IBD Patients - Oct 10, 2007 Newswise — Researchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal ... newswise.com Article: Once-daily mesalamine stalls ulcerative colitis.(Gastroentero... - Dec 15, 2005 Once-daily mesalamine stalls ulcerative colitis.(Gastroenterology) ... find Internal Medicine News articles. HONOLULU -- A novel, once-daily high-strength ... Pay-Per-View - Internal Medicine News - HighBeam Research … LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine - Mar 26, 2008 Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative ... Pay-Per-View - PR Newswire - HighBeam Research … Analyses Of Long-Term LIALDA(TM) (mesalamine) Data Presented At … - Oct 16, 2007 Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's (LSE: SHP, Nasdaq: SHPGY, ... Medical News Today - Medical News Today (press release) … LIALDA(TM) (Mesalamine), the First Oral Once-Daily Mesalamine - Mar 26, 2008 Shire and TAP Agree to Co-promote LIALDA(TM) (Mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Higher Dose of Mesalamine Is More Effective in … - May 17, 2005 Higher Dose of Mesalamine Is More Effective in Moderately Active Ulcerative Colitis. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Mesalamine Linked To Cancer Protection For High Risk Inflammatory … - Oct 15, 2007 ScienceDaily (Oct. 15, 2007) — Researchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in ... sciencedaily.com Ulcerative Colitis Remission Rates from Lialda Presented at DDW - May 30, 2007 Scotland in March 2007 showed Shire plc's Lialdaâ„¢ (mesalamine) is well ... Lialda is the first and only oral once-daily mesalamine on the market. ... EndoNurse Salix files for gran mesalamine appro in USA. - Jan 7, 2008 North Carolina, USA-based Salix Pharmaceuticals has submitted to the Food and Drug Administration (FDA) a New Drug Application seeking approval to market ... $4.95 - Pharma Marketletter - ECNext Mesalamine, folic acid cut cancer risk in IBD.(Digestive Disorders) - Dec 1, 2007 PHILADELPHIA -- Treatment with either folic acid or mesalamine was linked to about a 90% reduction in the incidence of colorectal cancer in a case-control ... Free with registration - Family Practice News - AccessMyLibrary.com DDW: Once-Daily Mesalamine Effective In Ulcerative Colitis - May 24, 2007 By Michael Smith, Senior Staff Writer, MedPage Today. WASHINGTON, May 24 -- For patients with active ulcerative colitis, an investigational once-daily ... MedPage Today Nonbiologic Therapy for IBD Revisited - Nov 15, 2007 In the era of targeted therapeutic approaches with biologics, various studies revisited the conventional wisdom of traditional drugs, including mesalamine ... Medscape … TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients... - Jan 17, 2007 FDA Approves LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: LIALDA(TM) (mesalamine) with MMX(TM) Technology - … - Mar 19, 2007 LIALDA(TM) (mesalamine) with MMX(TM) Technology - the First Oral Once-Daily Mesalamine for Active, Mild to Moderate Ulcerative Colitis - Now Available. from ... Pay-Per-View - PR Newswire - HighBeam Research … PLC - FDA Approves LIALDA first once-daily mesalamine for UC. - PR... - Jan 17, 2007 SHIRE PLC - FDA Approves LIALDA first once-daily mesalamine for UC. from PR Newswire UK Disclose. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Quick quality of life improvements with UC drug - Dec 4, 2006 The company's delayed release Asacol (mesalamine) tablets were given to almost 350 patients, with statistically significant improvements recorded on a ... Hays Pharma Press Release: LIALDA(TM) (mesalamine) With MMX(TM) Technology - … - Mar 19, 2007 LIALDA(TM) (mesalamine) With MMX(TM) Technology - the First Oral Once-Daily Mesalamine for Active, Mild to Moderate Ulcerative Colitis - Now Available. from ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: LIALDA(TM) (mesalamine) With MMX(TM) Technology - … - Mar 19, 2007 LIALDA(TM) (mesalamine) With MMX(TM) Technology - The First Oral Once-Daily Mesalamine for Active, Mild to Moderate Ulcerative Colitis - Now Available. from ... Pay-Per-View - PR Newswire Europe - HighBeam Research Salix Reports Granulated Mesalamine Study Results - Oct 8, 2007 Salix Pharmaceuticals has completed the second of two Phase III registration trials to evaluate the safety and efficacy of the company's new granulated ... FDA news - FDA news (subscription) Infliximab With Low-Dose Methotrexate for Prevention of Postsurgical ... - Sep 10, 2007 Controls were given mesalamine-coated tablets, 800 mg 3 times daily, starting from 2 ... The group treated with mesalamine also tolerated the drug well, ... Archives of Internal Medicine … Announces Submission of Granulated Mesalamine New Drug Application … - Dec 31, 2007 ..."This granulated mesalamine formulation combines an enteric pH-dependent coating, ... Additionally, we believe that granulated mesalamine, if and when ... $4.95 - Business Wire - ECNext … TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients... - Jan 17, 2007 FDA Approves LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients... - Jan 17, 2007 FDA Approves LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis. from PR Newswire ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Asacol(R)(Mesalamine) Sponsors ScriptAssist Nurse Call... - Jan 17, 2007 Asacol(R)(Mesalamine) Sponsors ScriptAssist Nurse Call-Back Program to Address Critical Issue of Medication Adherence. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Salix Pharmaceuticals to Present at NCINVEST Conference. - Feb 9, 2005 A granulated mesalamine product also is under development. Salix trades on the Nasdaq National Market under the ticker symbol "SLXP". ... Free with registration - Business Wire - AccessMyLibrary.com Study Data Show Asacol(R) (Mesalamine) Is Effective In Treating All … - Dec 6, 2007 Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic ... Medical News Today - Medical News Today (press release) Article: Mesalamine, folic acid may cut colorectal ca in IBD patients.... - Feb 15, 2008 Mesalamine, folic acid may cut colorectal ca in IBD patients.(Gastroenterology)(inflammatory bowel disease) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Granulated mesalamine (mesalazine in Europe).(Selected literature)( … - Apr 1, 2007 Granulated mesalamine (mesalazine in Europe). Marakhouski Y, Fixa B, Holoman J, et al; The International Salofalk Study Group. ... Free with registration - Formulary - AccessMyLibrary.com Press Release: Study Data Show Asacol(R) (Mesalamine) is Effective in... - Dec 5, 2007 Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at … - Oct 15, 2007 New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Treating Crohn's Disease With Medication - Jan 17, 2006 Sulfasalazine, Mesalamine, and Corticosteroids are the most common forms of anti-inflammatory ... Mesalamine is used less, but has far less side effects. ... Buzzle Lialda (mesalamine) with MMX Technology, is now available from Shire ... - Apr 16, 2007 Lialda (mesalamine) with MMX Technology, is now available from Shire USA Inc., Wayne, Pa., (800) 828-2088. Lialda (mesalamine) with MMX Technology, ... $9.94 - Drug Topics - Alacra Store Practice Guidelines - Feb 1, 2005 The combination of oral and topical ASAs is more effective than either alone (oral mesalamine, 2.4 g per day and 4 g per day mesalamine enema) (Evidence A). ... AAFP News Now Granulated mesalamine (mesalazine in Europe). - Apr 1, 2007 Granulated mesalamine (mesalazine in Europe). Marakhouski Y, Fixa B, Holoman J, et al; The International Salofalk Study Group. ... $9.94 - Formulary - Alacra Store … : Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients... - Jun 17, 2008 Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Granulated mesalamine (mesalazine in Europe).(Selected literature)( … - Apr 1, 2007 Granulated mesalamine (mesalazine in Europe). Marakhouski Y, Fixa B, Holoman J, et al; The International Salofalk Study Group. $4.95 - Formulary - ECNext Curcumin helps maintain remission in patient with ulcerative colitis.(... - Jun 1, 2007 Other than sulfasalazine or mesalamine, patients were required to stop all other medications. Outcome Measures: CAI was measured at entry (two weeks before ... $4.95 - Original Internist - ECNext … Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom... - Oct 15, 2007 New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Data From Two Pivotal Phase III Studies Presented … - May 24, 2006 Studies of a novel formulation of 5-ASA (mesalamine) demonstrated ... The data demonstrated that MMX mesalamine induced remission in patients with active ... Pay-Per-View - PR Newswire - HighBeam Research FDA Approvals: Lialda and Olux-E - Jan 25, 2007 On January 16, the FDA approved mesalamine 1.2-g delayed-release tablets ... Findings from both studies showed that mesalamine 2.4 and 4.8 g/day were ... Medscape Salix Pharmaceuticals Reports 3Q2007 Results. - Nov 6, 2007 ..."Also during the quarter we announced the successful completion of two Phase III trials to assess the efficacy and safety of our granulated mesalamine for ... $4.95 - Business Wire - ECNext The pharmacologic management of Crohn's disease. - Mar 1, 2008 Several formulations containing mesalamine without the sulfapyridine molecule have been ... (6,16) The determination of which mesalamine product should be ... $9.94 - Formulary - Alacra Store … Rates from Long-term Safety Study of LIALDA(TM) (mesalamine) Presen - May 22, 2007 Mesalamine has been associated with an acute intolerance syndrome (three percent of patients in clinical trials with mesalamine or sulfasalazine) that may ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Shire Announces Results from a Multidisciplinary … - Oct 6, 2008 Article: New Analyses of Long-Term LIALDA(TM) (mesalamine) Data ... ... TAP Pharmaceutical Products Inc. for LIALDA(TM) (mesalamine) with MMX(R) technology ... Pay-Per-View - PR Newswire - HighBeam Research Balsalazide for treatment of mild to moderate ulcerative colitis - Feb 10, 2006 Mesalamine is composed of 5-ASA itself, whilst balsalazide is a newer ... (Source: Pruitt, R. et al, 'Balsalazide is superior to mesalamine in the time to ... Virtual Medical Centre - The Virtual Medical Centre Safety and Efficacy Results Presented From Largest Prospective … - May 20, 2008 ..."In this study the investigational 800 mg mesalamine tablet dosed at 4.8 g/day was well-tolerated and helped patients with moderately active UC manage their ... RedOrbit Press Release: SHIRE PLC - LIALDA with MMX Technology for UC now … - Mar 19, 2007 A study found that patients who are not compliant with their mesalamine ... Mesalamine has been associated with an acute intolerance syndrome (three percent ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Press Release: Procter & Gamble Pharmaceuticals Commemorates 15 … - Jan 31, 2007 ILLUSTRATION OMITTED] Asacol HD (mesalamine delayed-release 800mg tabs, ... LIALDA[R] (mesalamine) versus Asacol[R] (mesalamine) that investigated ... have ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Following a Good Start to the Year Shire Reaffirms... - Apr 25, 2008 Drug Administration (FDA) has approved LIALDA(TM) (mesalamine ... ulcerative ... Shire's GI team has made Lialda the fastest growing brand of mesalamine ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Analysis of Ulcerative Colitis (UC) Time to Symptom … - May 20, 2008 Article: New Analyses of Long-Term LIALDA(TM) (mesalamine) Data ... ... MMX Mesalamine ... Eight Weeks: How Long Before Symptom Resolution? ... Pay-Per-View - PR Newswire - HighBeam Research Recommended Approach to the Asymptomatic Patient With IBD - Jan 5, 2006 I would start with high-dose mesalamine to hopefully avoid the need for ... I would continue maintenance mesalamine therapy for at least several years ... Medscape Combined oral and topical mesalazine treatment for extensive ulcerativ... - Nov 30, 2005 The patient was treated with oral mesalazine (mesalamine) 2.4 g/day initially, ... (1993) Mesalamine capsules for treatment of active ulcerative colitis: ... Nature.com New once-daily colitis drug may improve compliance. - Feb 19, 2007 Lialda is a delayed-release mesalamine product that utilizes MMX technology, ... Although the mechanism of action of mesalamine is not completely understood ... $9.94 - Drug Topics - Alacra Store Long-term safety data on Lialda published in leading GI journal - Jun 17, 2008 Mesalamine has been associated with an acute intolerance syndrome (three percent of patients in clinical trials with mesalamine or sulfasalazine) that may ... eurekalert.org |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |